<DOC>
	<DOCNO>NCT02923258</DOCNO>
	<brief_summary>This randomize , control , phase III , open label study postoperative concurrent chemoradiotherapy Docetaxel versus Cisplatinum high-risk squamous cell carcinoma head neck ( HNSCC ) .The primary purpose study evaluate efficacy safety concurrent chemoradiotherapy docetaxel HNSCC patient .</brief_summary>
	<brief_title>Postoperative CCRT With Docetaxel v Cisplatin High Risk HNSCC</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1.Histologically confirm squamous cell carcinoma head neck.Site tumor origin oral cavity , oropharynx , larynx , hypopharynx ( exclude nasopharynx , sinus ) 2 . Gross total resection , pathology demonstrate one follow risk factor : 1 . Histologic extracapsular nodal extension 2 . Histologic involvement â‰¥ 2 regional lymph node 3 . Invasive cancer see microscopic evaluation resection margin , evidence gross tumor residual 3 . No evidence distant metastases 4 . No synchronous concurrent head neck primary tumor 5 . Karnofsky score 60 6 . Adequate organ function include follow : 1 . Absolute neutrophil count ( ANC ) &gt; = 1.5 * 10^9/l 2 . Platelets count &gt; = 100 * 10^9/l 3 . Hemoglobin &gt; = 10 g/dl 4 . AST ALT &lt; = 2.5 time institutional upper limit normal ( ULN ) 5 . Total bilirubin &lt; = 1.5 time institutional ULN 6 . Creatinine clearance &gt; = 50 ml/min 7 . Serum creatine &lt; = 1 time ULN 7.Signed write informed consent 1 . Evidence distant metastasis 2 . Prior chemotherapy anticancer biologic therapy type cancer , prior radiotherapy head neck region 3 . Other previous cancer , except situ cervical cancer cutaneous basal cell carcinoma 4 . Pregnant breastfeeding female , female male childbearing potential take adequate contraceptive measure 5.Presence uncontrolled concomitant illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>head neck squamous cell carcinoma</keyword>
	<keyword>concurrent chemotherapy</keyword>
	<keyword>High-Risk</keyword>
</DOC>